# Accendra Health, Inc. (ACH) · Edgar & Edgarette company card

> Accendra Health, Inc. (ACH) grew revenue 3.1% in FY2025 to $2.8 billion, operating margin 1.0% against a 3.5% median for medical, dental & hospital equipment & supplies, equity -18.8% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 75252 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/ACH) · [JSON](https://www.pops4.com/boards/company/ACH.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $2.8B |
| Revenue growth, 1 year | 3.1% |
| Revenue growth per year | -27.1% |
| Operating margin | 1.0% (prior year -8.1%) |
| Net margin | -39.8% |
| Operating cash flow | — |
| Capital spending | $191M |
| Free cash flow | — |
| Cash | $282M |
| Long-term debt | $1.8B |
| Total assets | $2.5B |
| Total equity | −$461M |
| Equity ÷ assets | -18.8% |
| Return on equity | — |
| Dividend per share | $0.01 |
| Dividend years rising | 0 |

## Readings, computed from those figures

- Altman Z: -2.59 (distress zone)
- Piotroski F: 2 of 9 (weak)
- Health Harbor boat: Old boat · three warning signs · liabilities exceed assets (often from years of share buybacks, not always distress); slow and jumpy: growing slower than its size class, with revenue that swings more; revenue is hard to predict: its 80% range is ±64%

## Edgarette's reading

Exposure: revenue $2.8B (FY2025), total debt $1.8B. Experience: revenue up 3.1% on the year, down 27.1% a year over 4 years; operating margin 1.0%, up from -8.1%. Soundness: equity -18.8% of assets (liabilities exceed assets). Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $1.1B and $4.8B next year (method v4.1: its own 4-year record of growth weighed at 50% against $1B–10B filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $614.3M to $8.4B. A statistical range, not company guidance. Against peers (9 filers, $50M+ revenue, its industry group): operating margin 1.0% against a 3.5% median; growth 3.1% against 4.0%.

Range logged 2026-09-24, receipt 78a2db9dfd4ef8fe, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 3.01 Exchange listing notice or transfer: 2, latest 2026-10-30 ([filing](https://www.sec.gov/Archives/edgar/data/75252/000110465926120716/0001104659-26-120716-index.htm))
- Item 5.02 Director or officer change: 7, latest 2026-11-03 ([filing](https://www.sec.gov/Archives/edgar/data/75252/000110465926122072/0001104659-26-122072-index.htm))

## Recent filings

- 8-K · filed 2026-11-03 · 5.02 Departure or Election of Directors; Appointment of Officers; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/75252/000110465926122072/0001104659-26-122072-index.htm)
- 8-K · filed 2026-11-02 · 1.01 Entry into a Material Definitive Agreement; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/75252/000110465926120905/0001104659-26-120905-index.htm)
- 8-K · filed 2026-10-30 · 3.01 Notice of Delisting or Failure to Satisfy a Listing Rule; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/75252/000110465926120716/0001104659-26-120716-index.htm)
- DEF 14A · filed 2026-10-29 · [filing](https://www.sec.gov/Archives/edgar/data/75252/000110465926120208/0001104659-26-120208-index.htm)
- 8-K · filed 2026-10-09 · 3.01 Notice of Delisting or Failure to Satisfy a Listing Rule; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/75252/000110465926115043/0001104659-26-115043-index.htm)
- 8-K · filed 2026-09-17 · 5.02 Departure or Election of Directors; Appointment of Officers; 7.01 Regulation FD Disclosure; 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/75252/000110465926108405/0001104659-26-108405-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0000075252.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=75252

## Cite

POPS4, Edgar & Edgarette: Accendra Health, Inc. (ACH) company card, from the company's own SEC filings, accessed 2026-11-04, https://www.pops4.com/boards/company/ACH. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.